Advancing ADMET prediction for major CYP450 isoforms: graph-based models, limitations, and future directions.

Area of Science:

• Computational Chemistry
• Pharmacology
• Artificial Intelligence in Drug Discovery

Background:

• Accurate Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictions are vital for drug discovery.
• Traditional ADMET prediction methods face limitations in cost, scalability, and translatability.
• Cytochrome P450 (CYP) enzyme metabolism is a key factor in drug safety and efficacy.

Purpose of the Study:

• To review the application of graph-based computational techniques for modeling CYP enzyme interactions.
• To explore the use of Graph Neural Networks (GNNs), Graph Convolutional Networks (GCNs), and Graph Attention Networks (GATs) in ADMET prediction.
• To highlight advancements in integrating multi-task learning, attention mechanisms, and explainable AI (XAI) for improved prediction accuracy and interpretability.

Main Methods:

• Comprehensive literature review of graph-based computational methods applied to CYP-mediated metabolism.
• Analysis of studies focusing on key CYP isoforms (CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4).
• Synthesis of methodologies integrating advanced AI techniques like GNNs, multi-task learning, and XAI.

Main Results:

• Graph-based approaches, particularly GNNs, demonstrate significant potential for precise ADMET property prediction.
• Integration of multi-task learning and attention mechanisms enhances model accuracy and interpretability.
• Explainable AI (XAI) contributes to understanding complex CYP enzyme-drug interactions.

Conclusions:

• Graph-based computational techniques offer a powerful alternative to traditional methods for ADMET prediction.
• Future research should focus on improving model scalability, incorporating experimental validation, and expanding enzyme-specific interaction analysis.
• These methods hold transformative potential for advancing drug development and safety evaluations.